Psyence Biomedical Ltd.

0.69
0.07 (10.47%)
At close: Mar 24, 2025, 2:41 PM

Psyence Biomedical Ltd. Income Statement

Year FY23 FY22 FY21
Revenue n/a n/a n/a
Cost of Revenue 240.00 n/a n/a
Gross Profit -240 n/a n/a
Operating Income -2.75M -1.29M -334.29K
Interest Income 2.13K 1.55K n/a
Pretax Income -51.16M 8.01M 8.23M
Net Income -51.16M 8.01M 8.23M
Selling & General & Admin 1.8M 1.29M 334.29K
Research & Development 954.59K 1.61M 137.24K
Other Expenses 879.34K n/a n/a
Operating Expenses 2.75M 1.29M 334.29K
Interest Expense 52.94K n/a n/a
Selling & Marketing Expenses 80.6K 7.03K 17.51K
Cost & Expenses 2.75M 1.29M 334.29K
Income Tax n/a n/a n/a
Shares Outstanding (Basic) 6.52M 32.67M 32.67M
Shares Outstanding (Diluted) 6.52M 32.67M 32.67M
EPS (Basic) -7.85 -0.64 0.25
EPS (Diluted) -7.85 -0.64 0.25
EBITDA -2.75M -1.29M -334.29K
Depreciation & Amortization 240.00 n/a n/a